Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment

Documenti analoghi

• Comparative effectiveness of angiotensin-converting-enzyme inhibitors: Is an ACE always an ace?
  di: Hernandez, Adrian F., et al.
  Pubblicazione: (2008)
• Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
  di: Rice, Gillian I., et al.
  Pubblicazione: (2004)
• Public expenditure and drug policies in Bulgaria in 2014
  di: Toni Yonkov Vekov, et al.
  Pubblicazione: (2015-11-01)
• The angiotensin-converting enzyme (ACE) gene family of Anopheles gambiae
  di: Burnham, Susan, et al.
  Pubblicazione: (2005)
• Angiotensin converting enzyme gene polymorphism and influence of ACE inhibition
  di: Arman, Q.
  Pubblicazione: (2010)